SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-015725
Filing Date
2022-04-25
Accepted
2022-04-25 16:08:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20003037x2_defa14a.htm DEFA14A 21199
2 ny20003037x2_nc01.jpg GRAPHIC 1933047
3 ny20003037x2_nc02.jpg GRAPHIC 1101787
  Complete submission text file 0001140361-22-015725.txt   3897836
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39743 | Film No.: 22849769
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences